Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 21

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

ExoU Induces Lung Endothelial Cell Damage and Activates Pro-Inflammatory Caspase-1 during Pseudomonas aeruginosa Infection

Hardy, Kierra S., Tuckey, Amanda N., Renema, Phoibe, Patel, Mita, Al-Mehdi, Abu-Bakr, Spadafora, Domenico, Schlumpf, Cody A., Barrington, Robert A., Alexeyev, Mikhail F., Stevens, Troy, Pittet, Jean-Francois, Wagener, Brant M., Simmons, Jon D., Alvarez, Diego F., Audia, Jonathon P. · 2022 · Toxins

Abstract

The Gram-negative, opportunistic pathogen Pseudomonas aeruginosa utilizes a type III secretion system to inject exoenzyme effectors into a target host cell. Of the four best-studied exoenzymes, ExoU causes rapid cell damage and death. ExoU is a phospholipase A2 (PLA2) that hydrolyses host cell membranes, and P. aeruginosa strains expressing ExoU are associated with poor outcomes in critically ill patients with pneumonia. While the effects of ExoU on lung epithelial and immune cells are well studied, a role for ExoU in disrupting lung endothelial cell function has only recently emerged. Lung endothelial cells maintain a barrier to fluid and protein flux into tissue and airspaces and regulate inflammation. Herein, we describe a pulmonary microvascular endothelial cell (PMVEC) culture infection model to examine the effects of ExoU. Using characterized P. aeruginosa strains and primary clinical isolates, we show that strains expressing ExoU disrupt PMVEC barrier function by causing substantial PMVEC damage and lysis, in a PLA2-dependent manner. In addition, we show that strains expressing ExoU activate the pro-inflammatory caspase-1, in a PLA2-dependent manner. Considering the important roles for mitochondria and oxidative stress in regulating inflammatory responses, we next examined the effects of ExoU on reactive oxygen species production. Infection of PMVECs with P. aeruginosa strains expressing ExoU triggered a robust oxidative stress compared to strains expressing other exoenzyme effectors. We also provide evidence that, intriguingly, ExoU PLA2 activity was detectable in mitochondria and mitochondria-associated membrane fractions isolated from P. aeruginosa-infected PMVECs. Interestingly, ExoU-mediated activation of caspase-1 was partially inhibited by reactive oxygen species scavengers. Together, these data suggest ExoU exerts pleiotropic effects on PMVEC function during P. aeruginosa infection that may inhibit endothelial barrier and inflammatory functions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/toxins14020152

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 72

  1. Feltman, 2001, Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa, Microbiology, 147, 2659, 10.1099/00221287-147-10-2659 · DOI · Paper page
  2. Hauser, 2002, Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa, Crit. Care Med., 30, 521, 10.1097/00003246-200203000-00005 · DOI · Paper page
  3. Savel, 2001, Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections, J. Infect. Dis., 183, 1767, 10.1086/320737 · DOI · Paper page
  4. Boucher, 2009, Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America, Clin. Infect. Dis., 48, 1, 10.1086/595011 · DOI · Paper page
  5. Pendleton, 2013, Clinical relevance of the ESKAPE pathogens, Expert Rev. Anti-Infect. Ther., 11, 297, 10.1586/eri.13.12 · DOI · Paper page
  6. Rice, 2008, Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE, J. Infect. Dis., 197, 1079, 10.1086/533452 · DOI · Paper page
  7. Frank, 1997, The exoenzyme S regulon of Pseudomonas aeruginosa, Mol. Microbiol., 26, 621, 10.1046/j.1365-2958.1997.6251991.x · DOI · Paper page
  8. Barbieri, 2000, Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin, Int. J. Med. Microbiol., 290, 381, 10.1016/S1438-4221(00)80047-8 · DOI
  9. Barbieri, 2004, Pseudomonas aeruginosa ExoS and ExoT, Rev. Physiol. Biochem. Pharmacol., 152, 79, 10.1007/s10254-004-0031-7 · DOI · Paper page
  10. Goranson, 1997, ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury, Mol. Microbiol., 25, 547, 10.1046/j.1365-2958.1997.4891851.x · DOI · Paper page
  11. Yahr, 1998, ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system, Proc. Natl. Acad. Sci. USA, 95, 13899, 10.1073/pnas.95.23.13899 · DOI · Paper page
  12. Anderson, 2011, Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU, Mol. Microbiol., 82, 1454, 10.1111/j.1365-2958.2011.07904.x · doi:10.1111/j.1365-2958.2011.07904.x
  13. Belyy, 2016, Actin activates Pseudomonas aeruginosa ExoY nucleotidyl cyclase toxin and ExoY-like effector domains from MARTX toxins, Nat. Commun., 7, 13582, 10.1038/ncomms13582 · DOI
  14. Fu, 1993, The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family, Proc. Natl. Acad. Sci. USA, 90, 2320, 10.1073/pnas.90.6.2320 · DOI · Paper page
  15. Housley, 2011, The Rickettsia prowazekii ExoU homologue possesses phospholipase A1 (PLA1), PLA2, and lyso-PLA2 activities and can function in the absence of any eukaryotic cofactors in vitro, J. Bacteriol., 193, 4634, 10.1128/JB.00141-11 · DOI
  16. Sato, 2006, Identification of superoxide dismutase as a cofactor for the Pseudomonas type III toxin, ExoU, Biochemistry, 45, 10368, 10.1021/bi060788j · DOI
  17. Allewelt, 2000, Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread, Infect. Immun., 68, 3998, 10.1128/IAI.68.7.3998-4004.2000 · DOI · Paper page
  18. Hattemer, 2012, Clinical outcomes of type III Pseudomonas aeruginosa bacteremia, Crit. Care Med., 40, 1157, 10.1097/CCM.0b013e3182377906 · DOI
  19. Schulert, 2003, Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia, J. Infect. Dis., 188, 1695, 10.1086/379372 · doi:10.1086/379372
  20. Hardy, K.S., Tessmer, M.H., Frank, D.W., and Audia, J.P. (2021). Perspectives on the Pseudomonas aeruginosa Type III Secretion System Effector ExoU and Its Subversion of the Host Innate Immune Response to Infection. Toxins, 13. · DOI
  21. Diaz, 2010, Pseudomonas aeruginosa cytotoxin ExoU is injected into phagocytic cells during acute pneumonia, Infect. Immun., 78, 1447, 10.1128/IAI.01134-09 · DOI
  22. Frank, 2001, Multiple domains are required for the toxic activity of Pseudomonas aeruginosa ExoU, J. Bacteriol., 183, 4330, 10.1128/JB.183.14.4330-4344.2001 · DOI
  23. Howell, 2013, Type III secretion of ExoU is critical during early Pseudomonas aeruginosa pneumonia, mBio, 4, e00032-13, 10.1128/mBio.00032-13 · doi:10.1128/mbio.00032-13
  24. Sato, 2004, ExoU is a potent intracellular phospholipase, Mol. Microbiol., 53, 1279, 10.1111/j.1365-2958.2004.04194.x · DOI · Paper page
  25. Sato, 2003, The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU, EMBO J., 22, 2959, 10.1093/emboj/cdg290 · DOI · Paper page
  26. Anderson, 2013, Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase, J. Biol. Chem., 288, 26741, 10.1074/jbc.M113.478529 · doi:10.1074/jbc.m113.478529
  27. Pankhaniya, 2004, Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU, Crit. Care Med., 32, 2293, 10.1097/01.CCM.0000145588.79063.07 · DOI
  28. Shaver, 2004, Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung, Infect. Immun., 72, 6969, 10.1128/IAI.72.12.6969-6977.2004 · DOI · Paper page
  29. Diaz, 2008, Pseudomonas aeruginosa induces localized immunosuppression during pneumonia, Infect. Immun., 76, 4414, 10.1128/IAI.00012-08 · DOI
  30. Lins, 2010, ExoU modulates soluble and membrane-bound ICAM-1 in Pseudomonas aeruginosa-infected endothelial cells, Microbes Infect., 12, 154, 10.1016/j.micinf.2009.11.005 · doi:10.1016/j.micinf.2009.11.005
  31. Pazos, M.A., Lanter, B.B., Yonker, L.M., Eaton, A.D., Pirzai, W., Gronert, K., Bonventre, J.V., and Hurley, B.P. (2017). Pseudomonas aeruginosa ExoU augments neutrophil transepithelial migration. PLoS Pathog., 13. · DOI
  32. Plotkowski, 2008, Lipid body mobilization in the ExoU-induced release of inflammatory mediators by airway epithelial cells, Microb. Pathog., 45, 30, 10.1016/j.micpath.2008.01.008 · DOI
  33. Sutterwala, 2007, Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome, J. Exp. Med., 204, 3235, 10.1084/jem.20071239 · DOI · Paper page
  34. Ferreira, 2015, ExoU-induced redox imbalance and oxidative stress in airway epithelial cells during Pseudomonas aeruginosa pneumosepsis, Med. Microbiol. Immunol., 204, 673, 10.1007/s00430-015-0418-x · DOI
  35. de Lima, C.D., Calegari-Silva, T.C., Pereira, R.M., Santos, S.A., Lopes, U.G., Plotkowski, M.C., and Saliba, A.M. (2012). ExoU activates NF-kappaB and increases IL-8/KC secretion during Pseudomonas aeruginosa infection. PLoS ONE, 7. · DOI
  36. Freitas, 2012, The infection of microvascular endothelial cells with ExoU-producing Pseudomonas aeruginosa triggers the release of von Willebrand factor and platelet adhesion, Mem. Inst. Oswaldo Cruz, 107, 728, 10.1590/S0074-02762012000600004 · doi:10.1590/s0074-02762012000600004
  37. Saliba, 2006, Implications of oxidative stress in the cytotoxicity of Pseudomonas aeruginosa ExoU, Microbes Infect., 8, 450, 10.1016/j.micinf.2005.07.011 · DOI
  38. Saliba, 2005, Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU, Cell. Microbiol., 7, 1811, 10.1111/j.1462-5822.2005.00635.x · DOI
  39. Wagener, B.M., Anjum, N., Christiaans, S.C., Banks, M.E., Parker, J.C., Threet, A.T., Walker, R.R., Isbell, K.D., Moser, S.A., and Stevens, T. (2020). Exoenzyme Y Contributes to End-Organ Dysfunction Caused by Pseudomonas aeruginosa Pneumonia in Critically Ill Patients: An Exploratory Study. Toxins, 12. · doi:10.3390/toxins12060369
  40. Bouillot, 2015, Pharmacological activation of Rap1 antagonizes the endothelial barrier disruption induced by exotoxins ExoS and ExoT of Pseudomonas aeruginosa, Infect. Immun., 83, 1820, 10.1128/IAI.00010-15 · doi:10.1128/iai.00010-15
  41. Renema, 2020, Exoenzyme Y induces extracellular active caspase-7 accumulation independent from apoptosis: Modulation of transmissible cytotoxicity, Am. J. Physiol. Lung Cell. Mol. Physiol., 319, L380, 10.1152/ajplung.00508.2019 · DOI
  42. Alvarez, 2016, Caspase-1 activation protects lung endothelial barrier function during infection-induced stress, Am. J. Respir. Cell Mol. Biol., 55, 500, 10.1165/rcmb.2015-0386OC · DOI
  43. Renema, 2020, cAMP signaling primes lung endothelial cells to activate caspase-1 during Pseudomonas aeruginosa infection, Am. J. Physiol. Lung Cell. Mol. Physiol., 318, L1074, 10.1152/ajplung.00185.2019 · DOI
  44. He, 2015, Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion, Cell Res., 25, 1285, 10.1038/cr.2015.139 · DOI · Paper page
  45. Martinon, 2002, The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta, Mol. Cell, 10, 417, 10.1016/S1097-2765(02)00599-3 · DOI · Paper page
  46. Shi, 2015, Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death, Nature, 526, 660, 10.1038/nature15514 · DOI · Paper page
  47. Strowig, 2012, Inflammasomes in health and disease, Nature, 481, 278, 10.1038/nature10759 · DOI · Paper page
  48. Thornberry, 1992, A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes, Nature, 356, 768, 10.1038/356768a0 · DOI · Paper page
  49. Lee, 2007, Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU, Infect. Immun., 75, 1089, 10.1128/IAI.01184-06 · DOI
  50. Morrow, 2016, Pseudomonas aeruginosa exoenzymes U and Y induce a transmissible endothelial proteinopathy, Am. J. Physiol. Lung Cell. Mol. Physiol., 310, L337, 10.1152/ajplung.00103.2015 · DOI
  51. Schmalzer, 2010, Activation of ExoU phospholipase activity requires specific C-terminal regions, J. Bacteriol., 192, 1801, 10.1128/JB.00904-09 · DOI
  52. Evavold, 2019, Inflammasomes: Threat-assessment organelles of the innate immune system, Immunity, 51, 609, 10.1016/j.immuni.2019.08.005 · DOI
  53. Jabir, 2015, Mitochondrial damage contributes to Pseudomonas aeruginosa activation of the inflammasome and is downregulated by autophagy, Autophagy, 11, 166, 10.4161/15548627.2014.981915 · DOI · Paper page
  54. Elliott, 2018, Cutting Edge: Mitochondrial assembly of the NLRP3 inflammasome complex is initiated at priming, J. Immunol., 200, 3047, 10.4049/jimmunol.1701723 · DOI · Paper page
  55. Merkwirth, 2009, Prohibitin function within mitochondria: Essential roles for cell proliferation and cristae morphogenesis, Biochim. Biophys. Acta, 1793, 27, 10.1016/j.bbamcr.2008.05.013 · DOI · Paper page
  56. Anderson, 2015, Ubiquitin activates patatin-like phospholipases from multiple bacterial species, J. Bacteriol., 197, 529, 10.1128/JB.02402-14 · DOI
  57. Klionsky, 2008, Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes, Autophagy, 4, 151, 10.4161/auto.5338 · DOI · Paper page
  58. Zhou, 2010, Thioredoxin-interacting protein links oxidative stress to inflammasome activation, Nat. Immunol., 11, 136, 10.1038/ni.1831 · DOI · Paper page
  59. Zhou, 2011, A role for mitochondria in NLRP3 inflammasome activation, Nature, 469, 221, 10.1038/nature09663 · DOI · Paper page
  60. Hauser, 1999, Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells, Infect. Immun., 67, 5530, 10.1128/IAI.67.10.5530-5537.1999 · DOI · Paper page
  61. Rabin, 2006, A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells, Infect. Immun., 74, 2552, 10.1128/IAI.74.5.2552-2561.2006 · DOI
  62. Stirling, 2006, Eukaryotic localization, activation and ubiquitinylation of a bacterial type III secreted toxin, Cell. Microbiol., 8, 1294, 10.1111/j.1462-5822.2006.00710.x · doi:10.1111/j.1462-5822.2006.00710.x
  63. Tyson, 2015, A novel phosphatidylinositol 4,5-bisphosphate binding domain mediates plasma membrane localization of ExoU and other patatin-like phospholipases, J. Biol. Chem., 290, 2919, 10.1074/jbc.M114.611251 · DOI
  64. Tyson, 2013, Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the Pseudomonas aeruginosa cytotoxin ExoU, Infect. Immun., 81, 2873, 10.1128/IAI.00414-13 · DOI
  65. Veesenmeyer, 2010, Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity, Infect. Immun., 78, 3346, 10.1128/IAI.00223-10 · doi:10.1128/iai.00223-10
  66. Broz, 2013, Measuring inflammasome activation in response to bacterial infection, Methods Mol. Biol., 1040, 65, 10.1007/978-1-62703-523-1_6 · DOI
  67. Bagayoko, S., Leon-Icaza, S.A., Pinilla, M., Hessel, A., Santoni, K., Pericat, D., Bordignon, P.J., Moreau, F., Eren, E., and Boyance, A. (2021). Host phospholipid peroxidation fuels ExoU-dependent cell necrosis and supports Pseudomonas aeruginosa-driven pathology. PLoS Pathog., 17. · doi:10.1101/2021.02.17.431580
  68. Pendyala, 2009, Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells, Antioxid. Redox Signal., 11, 747, 10.1089/ars.2008.2203 · DOI · Paper page
  69. Sawa, 1999, Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury, Nat. Med., 5, 392, 10.1038/7391 · DOI · Paper page
  70. Vallis, 1999, Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells, Infect. Immun., 67, 2040, 10.1128/IAI.67.4.2040-2044.1999 · DOI
  71. Audia, J.P., Lindsey, A.S., Housley, N.A., Ochoa, C.R., Zhou, C., Toba, M., Oka, M., Annamdevula, N.S., Fitzgerald, M.S., and Frank, D.W. (2013). In the absence of effector proteins, the Pseudomonas aeruginosa type three secretion system needle tip complex contributes to lung injury and systemic inflammatory responses. PLoS ONE, 8. · DOI
  72. Benson, 2010, A sensitive fluorescence-based assay for the detection of ExoU-mediated PLA2 activity, Clin. Chim. Acta, 411, 190, 10.1016/j.cca.2009.10.025 · doi:10.1016/j.cca.2009.10.025

Cited by

See all 21

Metadata

Authors
Hardy, K. S., Tuckey, A. N., Renema, P., Patel, M., Al-Mehdi, A.-B., Spadafora, D., Schlumpf, C. A., Barrington, R. A., Alexeyev, M. F., Stevens, T., Pittet, J.-F., Wagener, B. M., Simmons, J. D., Alvarez, D. F., & Audia, J. P.
Affiliations
  • Department of Microbiology and Immunology, College of Medicine, University of South Alabama, Mobile, AL 36688, USA
  • Center for Lung Biology, College of Medicine, University of South Alabama, Mobile, AL 36688, USA
  • Flow Cytometry Core Lab, College of Medicine, University of South Alabama, Mobile, AL 36688, USA
  • Department of Anesthesiology and Perioperative Medicine, Birmingham School of Medicine, University of Alabama, Birmingham, AL 35294, USA
Venue
Toxins
Publisher
MDPI AG
Published
2022-02-18
Volume
14
Issue
2
Pages
152
ISSN
2072-6651
Cited by
21
References
3
Language
en
Funders
National Heart Lung and Blood Institute (HL118334, HL118334-S1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ExoU Induces Lung Endothelial Cell Damage and Activates Pro-Inflammatory Caspase-1 during Pseudomonas aeruginosa Infection. https://app.cochat.ai/papers/10.3390/toxins14020152
The paper
Hardy, K. S., Tuckey, A. N., Renema, P., Patel, M., Al-Mehdi, A.-B., Spadafora, D., Schlumpf, C. A., Barrington, R. A., Alexeyev, M. F., Stevens, T., Pittet, J.-F., Wagener, B. M., Simmons, J. D., Alvarez, D. F., & Audia, J. P. (2022). ExoU Induces Lung Endothelial Cell Damage and Activates Pro-Inflammatory Caspase-1 during Pseudomonas aeruginosa Infection. Toxins. https://doi.org/10.3390/toxins14020152

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.